[Therapy of irritable bladder and urinary incontinence].
D004629:Emepronium / Q000627:therapeutic use; D004964:Estriol / Q000627:therapeutic use; D005260:Female; D005422:Flavoxate / Q000627:therapeutic use; D006801:Humans; D008879:Midodrine / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*
D000644:Quaternary Ammonium Compounds; D004629:Emepronium; D005422:Flavoxate; D008879:Midodrine; D004964:Estriol
Therapie bei Reizblase und Harninkontinenz.